Pfizer Cash Flow Statement (2009-2026) | PFE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2020	Dec2020	Apr2021	Jul2021	Oct2021	Apr2022	Jul2022	Oct2022	Apr2023	Jul2023	Oct2023	Dec2023	Mar2024	Jun2024	Sep2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	0.56B		0.00B	-0.24B	-0.01B	-0.01B	0.03B	-0.02B	0.00B	-0.00B	0.01B	-0.03B	-0.01B	0.02B	-0.01B		0.03B			-0.01B
Share-based Compensation (Quarter)	0.47B		0.17B	0.22B	0.69B	0.09B	0.29B	0.51B	0.10B	0.15B	0.15B	0.12B	0.22B	0.21B	0.70B	0.17B	0.20B	0.20B	0.23B	0.27B
Deferred Taxes (Quarter)	-0.73B		0.20B	-0.07B	-3.61B	-2.32B	-1.14B	-3.40B	-0.60B	-0.87B	-0.11B	-1.86B	-0.44B	-0.78B	-1.71B	-0.66B	-0.27B	-0.77B	-0.43B	-0.01B
Cash from Discontinued Operations (Quarter)	2.41B		-0.01B	0.02B	-0.33B		-0.01B
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	0.31B	1.25B	-0.16B	2.35B	2.94B	-0.81B	-0.46B	0.20B	0.02B	0.30B	2.59B	-2.29B	0.18B	-0.17B	0.01B	0.15B	-0.44B	-0.01B	4.99B	-0.02B
Asset Writedowns and Impairment (Quarter)	0.90B		0.02B	0.03B		0.03B		0.20B	0.27B			2.50B	0.14B	0.24B		0.22B	0.09B	0.26B	-0.58B	0.03B
Non-cash Items (Quarter)
Cash from Operations (Quarter)	6.36B		4.54B	11.30B	26.99B	6.54B	8.17B	20.68B	1.21B	-1.21B	3.46B	5.24B	1.09B	-1.78B	6.02B	2.33B	-0.58B	4.60B	5.35B	2.62B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	3.57B		1.21B	1.31B	3.86B	1.19B	1.18B	3.54B	1.49B	1.57B	1.56B	1.67B	1.74B	1.73B	1.75B	1.62B	1.62B	1.66B	1.69B	1.61B
Change in Working Capital
Other Working Capital Changes (Quarter)	2.86B		1.28B	-5.38B	-10.87B	0.73B	2.77B	8.08B	5.51B	3.92B	1.20B	-9.96B	3.34B	3.54B	5.99B	1.92B	4.99B	0.04B	-8.23B	1.73B
Investing Activities
Capital Expenditures (Quarter)	1.41B		0.55B	0.54B	1.71B	0.64B	0.75B	2.23B	1.14B	0.91B	0.81B	1.04B	0.70B	0.64B	1.99B	0.56B	0.62B	0.60B	0.84B	0.44B
Change in Intangibles (Quarter)	0.04B
Acquisitions (Quarter)						6.22B		6.22B		0.03B		43.41B
Divestments (Quarter)	-11.47B			-0.00B				3.96B					3.49B		3.49B	6.31B	6.30B	-6.30B
Change in Acquisitions & Divestments (Quarter)	8.40B		5.46B	2.11B	15.85B	13.42B	6.73B	35.09B	6.40B	6.19B	5.42B	21.25B	0.66B	1.05B	2.63B	3.96B	6.54B	2.74B	4.72B	4.58B
Cash from Investing Activities (Quarter)	-12.60B		-1.75B	-8.14B	-19.95B	0.57B	-11.31B	-11.37B	3.31B	-25.48B	0.89B	-11.00B	1.73B	4.60B	4.28B	3.27B	3.95B	-2.43B	-6.15B	0.79B
Financing Activities
Other financing activities (Quarter)	-0.17B		-0.61B	0.10B	-0.18B	-0.50B	0.15B	-0.34B	-0.44B	-0.14B	-0.04B	-0.02B	-0.39B	-0.06B	-0.46B	-0.36B	-0.02B	-0.04B	-0.04B	-0.28B
Cash from Financing Activities (Quarter)	-7.26B		-2.81B	-2.56B	-6.46B	-6.58B	2.52B	-9.82B	-2.77B	27.17B	-3.78B	5.44B	-4.93B	-2.46B	-12.03B	-5.23B	-3.20B	-2.48B	0.60B	-2.86B
Dividend Payments
Dividends Paid - Common (Quarter)	6.33B		2.17B	2.18B	6.54B	2.25B	2.24B	6.74B	2.30B	2.31B	2.31B	2.31B	2.37B	2.38B	7.13B	2.44B	2.44B	2.44B	2.44B	2.44B
Additional items
Exchange Rate Effect (Quarter)	-0.04B			0.01B	-0.03B	-0.00B	-0.07B	-0.14B	-0.00B	-0.01B	-0.03B	-0.00B	-0.03B	-0.02B	-0.04B	-0.01B	0.04B	0.00B	0.01B	0.02B
Change in Cash (Quarter)	0.28B		-0.01B	0.61B	0.21B	0.53B	-0.69B	-0.65B	1.75B	0.47B	0.54B	-0.32B	-2.14B	0.34B	-1.76B	0.38B	0.21B	-0.30B	-0.20B	0.56B
Free Cash Flow (Quarter)	4.95B		3.98B	10.76B	25.28B	5.90B	7.42B	18.45B	0.07B	-2.12B	2.65B	4.20B	0.39B	-2.42B	4.03B	1.77B	-1.20B	4.00B	4.50B	2.18B
Net Cash Flow (Quarter)	-13.49B		-0.02B	0.60B	0.58B	0.53B	-0.62B	-0.51B	1.76B	0.48B	0.56B	-0.31B	-2.11B	0.36B	-1.73B	0.38B	0.17B	-0.30B	-0.20B	0.54B

Research Tools

Pfizer Cash Flow Statement (2009-2026) | PFE

Create an account

Sign In

Reset Password